Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BLT | Good results ? | 22/04/24 | 1 | 230 | |||
|
|||||||
BLT | Benitec Biopharma's Oculopharyngeal Muscular Dystrophy ... | 14/02/24 | 1 | 485 | |||
|
|||||||
BLT | Letter received - YOUR IMMEDIATE ACTION IS REQUIRED PER DELAWARE UNCLAIMED PROPERTY LAWS | 11/12/23 | 2 | 853 | |||
|
|||||||
BLT | NEO Compensation | 03/12/23 | 7 | 3.8K | |||
|
|||||||
BLT | OPMD update | 04/07/23 | 5 | 1.8K | |||
|
|||||||
BLT | Morgan Stanley increases their stake to 5.2% | 21/10/21 | 1 | 1.4K | |||
|
|||||||
BLT | CSL and RNAi | 07/03/21 | 21 | 257K | |||
|
|||||||
BLT | Ann: Benitec Provides Update on BB-301 OPMD Program | 04/03/21 | 66 | 23K | |||
|
See All Discussions